Market Tracker

03/02 7:29am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

413.84
Delayed Data
As of Feb 27
 -6.03 / -1.44%
Today’s Change
269.50
Today|||52-Week Range
437.64
+0.88%
Year-to-Date

Today’s Trading

Previous close419.87
Today’s open421.04
Day’s range-- - --
Volume811,008
Average volume (3 months)828,319
Market cap$42.5B
Dividend yield--
Data as of 02/27/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+4.30%
Earnings growth (next 5 years)+15.72%
Revenue growth (last year)+33.96%
P/E ratio134.8
Price/Sales14.64
Price/Book16.67

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-2.86-2.74%
ISISIsis Pharmaceuticals...+1.23+1.83%
QQuintiles Transnatio...+0.03+0.05%
ICLRICON PLC-0.43-0.62%
Data as of 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.70
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts